LIVN · LivaNova PLC · Executive Compensation

$78.18 +0.00 (+0.00%) At close · Sep 11

S&P 400 member Russell 2000 member Rebalance outlook locked

Market Cap

$4.31B

55.09M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Damien McDonald	Former CEO	$286,826	—	$4,746,297	$1,624,996	—	$1,552,221	$8,210,340
Marco Dolci	Former President, Cardiopulmonary BU	$571,833	—	$2,094,554	$1,046,774	—	$1,089,127	$4,802,288
William Kozy	Former Interim CEO	$697,500	—	$1,249,961	—	$1,058,542	$54,722	$3,060,725
Alex Shvartsburg	CFO	$536,885	—	$1,168,289	$399,992	$480,483	$185,531	$2,771,180
Michael Hutchinson	Senior Vice President, Chief Legal Officer and Company Secretary	$505,077	$100,000	$730,181	$249,983	$451,424	$35,686	$2,072,351
Trui Hebbelinck	CHRO	$396,347	—	$657,120	$224,994	$354,284	$144,415	$1,777,160

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Damien McDonald	Former CEO	$967,450	—	$4,883,235	$1,249,995	$1,105,422	$359,443	$8,565,545
Keyna Skeffington	Senior Advisor and Former SVP and General Counsel	$453,951	—	$870,191	$508,982	$290,467	$155,927	$2,279,518
Marco Dolci	Former President, Cardiopulmonary BU	$537,617	—	$813,760	$249,978	$407,944	$198,728	$2,208,027
Alex Shvartsburg	CFO	$434,231	—	$976,502	$299,966	$258,051	$159,916	$2,128,666
Trui Hebbelinck	CHRO	$377,873	—	$732,378	$224,966	$224,516	$129,018	$1,688,751

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Damien McDonald	Former CEO	$1,056,456	—	$5,349,239	$1,249,971	$1,884,453	$540,525	$10,080,644
Marco Dolci	Former President, Cardiopulmonary BU	$591,140	—	$891,335	$249,988	$506,134	$190,807	$2,429,404
Keyna Skeffington	Senior Advisor and Former SVP and General Counsel	$495,716	—	$891,335	$249,988	$495,170	$198,150	$2,330,359
Alex Shvartsburg	CFO	$431,476	—	$891,335	$249,988	$314,453	$142,107	$2,029,359
Trui Hebbelinck	CHRO	$412,638	—	$713,172	$199,973	$382,742	$149,940	$1,858,465

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Damien McDonald	Former CEO	$973,663	—	$4,371,196	$1,249,834	—	$307,660	$6,902,353
Thad Huston	(Former) Chief Financial Officer	$531,281	—	$1,456,981	$499,937	$71,723	$131,464	$2,691,386
Marco Dolci	President, Cardiopulmonary BU	$570,190	—	$728,427	$249,960	$51,317	$122,641	$1,722,535
Keyna Skeffington	Senior Advisor and Former SVP and General Counsel	$455,828	—	$728,427	$249,961	$47,866	$119,585	$1,601,667
Roy Khoury	(Former) President International Region and Senior Vice President Global Strategic Marketing	$391,297	—	$728,427	$249,960	$38,151	$87,482	$1,495,317
Alex Shvartsburg	CFO	$321,104	—	$572,817	$122,923	$46,243	$77,942	$1,141,029

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Damien McDonald	CEO	$933,202	—	$4,309,277	$1,249,978	$277,244	$362,226	$7,131,927
Thad Huston	(Former) Chief Financial Officer	$510,694	—	$1,519,670	$499,998	$170,088	$139,192	$2,839,642
Trui Hebbelinck	CHRO	$424,183	—	$683,719	$224,988	$106,289	$128,751	$1,567,930
Keyna Skeffington	Senior Vice President and General Counsel	$424,183	—	$683,719	$224,988	$106,289	$128,751	$1,567,930

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Damien McDonald	Chief Executive Officer	$951,218	—	$3,522,492	$1,124,847	$999,131	$514,940	$7,112,628
Thad Huston	(Former) Chief Financial Officer	$511,458	—	$1,174,164	$374,940	$480,257	$431,233	$2,972,052
Keyna Skeffington	Senior Vice President and General Counsel	$410,166	—	$658,627	$162,473	$251,619	$134,393	$1,617,278

Executive changes

Person	Role	Change	Effective	Filed
Michael Hutchinson	Senior Vice President, Chief Legal Officer, and Company Secretary	Resigned	2026-01-26	2026-01-14
Donald Zurbay	Director	Appointed	2025-09-04	2025-09-04
Peter Wilver	director	Appointed	2025-06-11	2025-06-11
Brooke Story	director	Appointed	2025-06-11	2025-06-11
Todd Schermerhorn	director	Appointed	2025-06-11	2025-06-11
Sharon O'Kane	director	Appointed	2025-06-11	2025-06-11
Susan Podlogar	director	Appointed	2025-06-11	2025-06-11
Stacy Enxing Seng	director	Appointed	2025-06-11	2025-06-11
Vladimir Makatsaria	director	Appointed	2025-06-11	2025-06-11
William A. Kozy	director	Appointed	2025-06-11	2025-06-11
Francesco Bianchi	director	Appointed	2025-06-11	2025-06-11
J. Christopher Barry	director	Appointed	2025-06-11	2025-06-11
Susan Podlogar	Director	Appointed	2024-10-08	2024-10-08

Key facts CIK 1639691 CUSIP G5509L101 13F (30d) 76 filings 75 filers Visit website Investor relations